|
SNORD116-4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20348175869367E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.41327008060944E-13 |
| Normal-vs-Stage2 |
1.79967152291738E-12 |
| Normal-vs-Stage3 |
1.63258295771129E-12 |
| Normal-vs-Stage4 |
5.99520433297585E-15 |
| Stage1-vs-Stage2 |
2.693600E-01 |
| Stage1-vs-Stage3 |
1.860460E-02 |
| Stage1-vs-Stage4 |
1.769930E-02 |
| Stage2-vs-Stage3 |
4.518800E-01 |
| Stage2-vs-Stage4 |
2.584800E-01 |
| Stage3-vs-Stage4 |
5.702000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.13575815419154E-13 |
| Normal-vs-AfricanAmerican |
3.78440000448066E-08 |
| Normal-vs-Asian |
3.8755665343615E-12 |
| Caucasian-vs-AfricanAmerican |
3.617200E-01 |
| Caucasian-vs-Asian |
7.999600E-01 |
| AfricanAmerican-vs-Asian |
5.029600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05391259555654E-14 |
| Normal-vs-Female |
2.11497486191092E-13 |
| Male-vs-Female |
1.620020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.35713662530179E-12 |
| Normal-vs-Age(41-60Yrs) |
1.73283609683494E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63324909152607E-12 |
| Normal-vs-Age(81-100Yrs) |
1.83289999999836E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.681000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.520400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.779600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.576400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.640400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.062400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.00360003325073E-09 |
| Classical-VS-Follicular |
6.920800E-01 |
| Classical-VS-Other |
2.796200E-01 |
| Classical-VS-Normal |
7.64055485547033E-13 |
| Tall-VS-Follicular |
3.795600E-04 |
| Tall-VS-Other |
4.110400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.727200E-01 |
| Follicular-VS-Normal |
1.13770104448463E-11 |
| Other-VS-Normal |
1.1627999996211E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74971148680925E-12 |
| Normal-vs-N1 |
7.0832228971085E-14 |
| N0-vs-N1 |
4.101200E-01 |
|
|
